• Toremifene vs Tamoxifen in Advanced Breast Cancer

  2026-09-13

  This Cochrane review evaluated whether toremifene offers clinically meaningful advantages over tamoxifen for advanced breast cancer. Its synthesis found no consistent evidence that either agent was superior across tumor response, time to progression, overall survival, or evaluated adverse events, supporting a cautious, evidence-based role for comparative endocrine therapy research.

• SERCA2–CaN/FoxO1/FABP4 Signaling in Atherosclerosis

  2026-09-12

  The reference study identifies the calcineurin/FoxO1/FABP4 axis as a mechanistic link between SERCA2 dysfunction, abnormal fatty acid handling, macrophage foam cell formation, and atherosclerotic progression. Its combination of a SERCA2 C674S knock-in model, metabolomics, macrophage assays, pathway inhibition, and lesion analysis provides a rationale for using FABP4-directed interventions as mechanistic tools in atherosclerosis research.

• Tigecycline in CREC Transmission Research

  2026-09-12

  Tigecycline is a glycylcycline antibiotic with value beyond routine susceptibility testing. This article shows how to integrate its bacteriostatic mechanism with plasmid-transfer and carbapenemase data when designing multidrug-resistant Enterobacter cloacae research.

• Dimetridazole BA1077: Reliable Assay Design

  2026-09-11

  Learn how Dimetridazole (SKU BA1077) can support reproducible antimicrobial, quorum-sensing, biofilm, and combination assays. This scenario-based guide connects documented solubility and storage data with published evidence on membrane disruption and cefotaxime potentiation in multidrug-resistant E. coli.

• Caspofungin: From Target Biology to Assay Design

  2026-09-11

  Caspofungin is a lipopeptide antifungal drug whose glucan-synthase mechanism enables rigorous studies of Candida cell-wall vulnerability. This article translates comparative C. auris evidence into practical assay decisions, interpretation safeguards, and research-use considerations.

• Iptacopan (LNP023): From C3bBb to Clinical Signal

  2026-09-10

  Iptacopan (LNP023) offers a translational route from selective factor B blockade to measurable control of complement-driven hemolysis. This article connects molecular mechanism, assay interpretation, animal evidence, and the pivotal PNH proof-of-concept findings to guide better complement activation research.

• BMS 309403: FABP4 Inhibitor Workflow

  2026-09-10

  BMS 309403 enables targeted testing of FABP4-dependent lipid handling, macrophage inflammation, and foam-cell formation. This workflow connects cell-based dose–response experiments with SERCA2–CaN–FoxO1 pathway analysis and translational atherosclerosis models.

• Cy5 Goat Anti-Mouse IgG for Exosome Assays

  2026-09-09

  Discover how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody can support mechanism-focused exosome and osteogenesis assays. This guide connects fluorescent detection strategy, assay controls, and lithium-driven Wnt10a research without confusing signal enhancement with mechanistic proof.

• Fosinopril Sodium: ACE Inhibitor Research Guide

  2026-09-09

  Fosinopril sodium is an oral prodrug ACE inhibitor that is hydrolyzed to fosinoprilat and used to study blood pressure, cardiac, and renal endpoints. Its reported 9 nM ACE-inhibition potency, phosphinic acid zinc-ion interaction, and renal-hepatic elimination profile support hypertension research while requiring careful assay and formulation controls.

• Methoxy-X04 Workflows for Amyloid Imaging

  2026-09-08

  Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe for connecting plaque burden, soluble aggregates, and microglial responses in Alzheimer’s disease models. This practical guide covers preparation, in vivo timing, tissue workflows, rTMS-related assay design, and troubleshooting for more reproducible amyloid imaging.

• Cimetidine in BBB and GI Cancer Research

  2026-09-07

  Cimetidine provides a practical way to connect H2 receptor biology with gastrointestinal cancer assays and exploratory barrier-permeability studies. This guide combines product-handling advice, Transwell workflow design, lysosomal-trapping controls, and troubleshooting for more interpretable research data.

• Methoxy-X04 Workflow for Amyloid Imaging

  2026-09-07

  Learn how to deploy Methoxy-X04 as a brain-permeable fluorescent amyloid beta probe for plaque, oligomer, and vascular amyloid studies. The workflow connects rapid in vivo imaging with exercise-induced extracellular-vesicle research and provides practical controls for reproducible quantification.

• Targeted Nano-Delivery for P. aeruginosa Wounds

  2026-09-05

  The 2025 Materials Today Bio study developed Apt-pM@UCNPmSiO2-Cur-CAZ, a targeted nanodelivery system combining a pretreated macrophage membrane, an aptamer, curcumin, ceftazidime, and upconversion nanoparticles. The construct improved antibacterial and antibiofilm activity, particularly under near-infrared irradiation, and promoted healing in a mouse model of Pseudomonas aeruginosa-infected wounds without evident major toxicity.

• Dimetridazole Disarms P. aeruginosa Virulence

  2026-09-05

  The reference study identified Dimetridazole and Ribavirin as antivirulence candidates that weaken Pseudomonas aeruginosa quorum sensing, reduce virulence-associated phenotypes, and improve the activity of selected antibiotics. Its combination of phenotypic assays, transcriptomics, gene-expression validation, drug synergy testing, and infection models provides a useful framework for evaluating quorum sensing inhibition beyond direct bacterial killing.

• Acetylcysteine in PDAC Co-Culture Assays

  2026-09-04

  Acetylcysteine can help interrogate redox-dependent behavior in patient-derived pancreatic cancer organoid–fibroblast models. This guide explains how to distinguish genuine oxidative stress pathway modulation from assay interference, stromal protection, or altered drug exposure.

7980 records 1/532 page Next 12345 下5页 Last page